TerrAscend Corp. (OTCMKTS:TSNDF) Short Interest Update

TerrAscend Corp. (OTCMKTS:TSNDF) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 2,621,900 shares, an increase of 53.8% from the February 28th total of 1,704,200 shares. Based on an average daily volume of 1,976,300 shares, the short-interest ratio is presently 1.3 days. Currently, 1.3% of the shares of the stock are short sold.

TerrAscend Price Performance

Shares of TerrAscend stock opened at $0.49 on Friday. The company has a quick ratio of 0.69, a current ratio of 1.35 and a debt-to-equity ratio of 0.81. The stock’s 50-day simple moving average is $0.52 and its 200-day simple moving average is $0.78. The company has a market capitalization of $142.16 million, a price-to-earnings ratio of -1.73 and a beta of 1.64. TerrAscend has a 52 week low of $0.38 and a 52 week high of $2.20.

TerrAscend (OTCMKTS:TSNDF) last posted its quarterly earnings data on Thursday, March 6th. The company reported $0.01 EPS for the quarter, beating analysts’ consensus estimates of ($0.03) by $0.04. TerrAscend had a negative return on equity of 31.48% and a negative net margin of 23.95%. The business had revenue of $74.35 million for the quarter, compared to analyst estimates of $72.37 million. As a group, analysts expect that TerrAscend will post -0.14 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Atb Cap Markets downgraded shares of TerrAscend from a “strong-buy” rating to a “hold” rating in a research report on Monday, December 9th.

TerrAscend Company Profile

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.